Ocrelizumab modifies circulating immune asset in relapsing-remitting multiple sclerosis subjects

被引：0
|
作者：
Abbadessa, Gianmarco [1 ]
Bruzzaniti, Sara [2 ]
Miele, Giuseppina [1 ]
Piemonte, Erica [3 ]
Signoriello, Elisabetta [1 ]
Lus, Giacomo [1 ]
Matarese, Giuseppe [3 ]
Galgani, Mario [3 ]
Bonavita, Simona [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Clin Neurol 2, Naples, Italy
[2] Univ Naples Federico II, Dipartimento Biol, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷
关键词：
D O I：
10.1016/j.jns.2021.118820
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
118820
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [31] Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Kornilov, Sergey A.
    Price, Nathan D.
    Gelinas, Richard
    Acosta, Juan
    Brunkow, Mary E.
    Gervasi-Follmar, Tiffany
    Winger, Ryan C.
    Aldershoff, Dmitri
    Lausted, Christopher
    Troisch, Pamela
    Smith, Brett
    Heath, James R.
    Repovic, Pavle
    Cohan, Stanley
    Magis, Andrew T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 467
  • [32] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
    Roos, Izanne
    Sharmin, Sifat
    Malpas, Charles
    Ozakbas, Serkan
    Lechner-Scott, Jeannette
    Hodgkinson, Suzanne
    Alroughani, Raed
    Eichau Madueno, Sara
    Boz, Cavit
    van der Walt, Anneke
    Butzkueven, Helmut
    Buzzard, Katherine
    Skibina, Olga
    Foschi, Matteo
    Grand'Maison, Francois
    John, Nevin
    Grammond, Pierre
    Terzi, Murat
    Prevost, Julie
    Barnett, Michael
    Laureys, Guy
    Van Hijfte, Liesbeth
    Luis Sanchez-Menoyo, Jose
    Blanco, Yolanda
    Oh, Jiwon
    Mccombe, Pamela
    Ramo Tello, Cristina
    Soysal, Aysun
    Prat, Alexandre
    Duquette, Pierre
    Yamout, Bassem, I
    Khoury, Samia
    van Pesch, Vincent
    Macdonell, Richard
    Jose Sa, Maria
    Slee, Mark
    Kuhle, Jens
    Maimone, Davide
    Spitaleri, Daniele L. A.
    Willekens, Barbara
    Asmi, Abdallah Al
    Tallantyre, Emma
    Robertson, Neil P.
    Coles, Alasdair
    Brown, J. William
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : 1163 - 1175
  • [33] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [34] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [35] A Case of Late-Onset Neutropenia in Relapsing-Remitting Multiple Sclerosis Following Ocrelizumab Therapy
    Alabdulqader, Reema A.
    Alnasser, Wafa
    Aljubran, Hussain J.
    Alkhulaif, Hassan H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [36] Comparison of the effectiveness of ocrelizumab vs interferons, fingolimod and natalizumab on relapses in relapsing-remitting multiple sclerosis
    Roos, I.
    Sharmin, S.
    Ozakbas, S.
    Horakova, D.
    Havrdova, E. K.
    Boz, C.
    Alroughani, R.
    Patti, F.
    Terzi, M.
    Lechner-Scott, J.
    Izquierdo, G.
    Eichau, S.
    Grammond, P.
    Buzzard, K.
    Skibina, O.
    Prat, A.
    Girard, M.
    Duquette, P.
    Soysal, A.
    Grand'Maison, F.
    Kuhle, J.
    van der Walt, A.
    Butzkueven, H.
    Turkoglu, R.
    Butler, E.
    Laureys, G.
    van Hijfte, L.
    Shaygannejad, V.
    Yamout, B.
    Khoury, S.
    Prevost, J.
    Sidhom, Y.
    Gouider, R.
    Cartechini, E.
    Sanchez-Menoyo, J. L.
    Sa, M. Jose
    Macdonell, R.
    van Pesch, V.
    Ramo-Tello, C.
    McCombe, P.
    Willekens, B.
    Spitaleri, D.
    Ampapa, R.
    Al-Asmi, A.
    Slee, M.
    Besora, S.
    Malpas, C.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 778 - 780
  • [37] Assessment of the lymphocyte repertoire in relapsing-remitting multiple sclerosis patients treated with ocrelizumab: the ImmunoReMS study
    Esposito, Federica
    Ferre, Laura
    Mascia, Elisabetta
    Sorosina, Melissa
    Clarelli, Ferdinando
    Santoro, Silvia
    Giordano, Antonino
    Cannizzaro, Miryam
    Moiola, Lucia
    Martinelli, Vittorio
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 815 - 815
  • [38] Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review
    Emma, Callanan
    Vesela, Petkova
    Kay, Polly
    Huseyin, Huseyin
    Alison, Hassett
    Mara, Sittampalam
    Floriana, De Angelis
    Sara, Collorone
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (07) : 893 - 897
  • [39] Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis (vol 80, pg 789, 2023)
    不详
    JAMA NEUROLOGY, 2023, 80 (10) : 1119 - 1119
  • [40] Comparing the Efficacy and Safety of Natalizumab and Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis and Spinal Lesions
    Huntemann, Niklas
    Mueller, Marc
    Masanneck, Lars
    Baumgart, Romy
    Axhausen, Franziska
    Wolff, Stephanie
    Kutsojannis, Bela
    Koelsche, Tristan
    Korsen, Melanie
    Pfeuffer, Steffen
    Meuth, Sven
    Pawlitzki, Marc
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 90 - 91
12345